The STS Global Income & Growth Trust follows a distinctive quality-focused, conservative investment style. We try to consider the downside to investments as much as the potential opportunity and to produce good risk-adjusted returns balanced between income and capital growth. We believe this approach is especially relevant today given that we consider the economic outlook to be murky at best, driven by the very material and rapid rise in interest rates around the world, and still elevated equity valuations, notably in the US.
In this context, we want to invest in companies that are predictable, boast well-entrenched competitive advantages, and have limited requirements for capital when growing their businesses. Such companies tend also to exhibit attractive margins, allowing them to weather more challenging economic environments, especially when combined with a generally higher level of inflation, as we see today.
1. CME (Nasdaq: CME)
A good example is CME, previously called the Chicago Mercantile Exchange (Nasdaq: CME). This company is extremely well placed to benefit from the structurally greater need to hedge inflation and interest-rate risk, as well as from other areas such as commodity prices. The post-quantitative easing world, together with the return of inflation, is likely to be characterised by greater volatility and uncertainty, to the benefit of this company. This leads to attractive margins and returns as well as generous shareholders’ returns. CME is a core long-term investment in the fund.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
2. Reckitt Benckiser (LSE: RKT)
The second company we highlight today is Reckitt Benckiser (LSE: RKT). It is a business that will be familiar to many owing to its well-known brands, such as Dettol and Nurofen. This consumer health and household products company has had a lacklustre few years owing to many problems that we now think are being fixed. Following a three-year turnaround, Reckitt is now well on its way to generating stable and reliable growth.
Despite the market’s scepticism, reflected in the company’s lowest valuation in a decade, Reckitt has achieved high-single-digit like-for-like sales growth since 2019, alongside enhanced capital efficiency and reduced financial leverage. Reinforcing confidence in its future, Reckitt raised its dividend by 5% last year, ending a prolonged period of stagnation, and announced a significant share-buyback programme, signalling strong growth prospects ahead.
One in six workers in the US is co-employed by outsourcing specialist ADP
3. ADP (Nasdaq: ADP)
Finally, we are excited about ADP (Nasdaq: ADP). This is a very high-quality company engaged in the provision of payroll and human capital management services to large and small companies, predominantly in the US. ADP’s employer services division offers payroll, human capital management solutions, human resources outsourcing, insurance and retirement services.
The smaller but faster-growing professional employer organisation segment provides HR outsourcing to small and medium-sized businesses through a co-employment model; one in six workers in the US is co-employed by ADP. Despite this scale, ADP still has ample scope for growth as many businesses do not yet outsource these functions. As the competition for talent intensifies and the provision of HR becomes more complex, the impetus to outsource builds. This resilience and quality were demonstrated by recent results and the company’s decision to raise its dividend by 20%.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Related articles
-
8 of the best houses for sale for around £500,000Some of the best houses for sale for around £500,000 – from a 19th-century stone farm cottage in North Yorkshire and a two-bedroom apartment in Edinburgh’s New Town to a converted Methodist chapel in Norfolk
-
What will the unravelling of US-China trade mean for the economy?What will a US-China decoupling mean for the global economy?
-
'Technology will determine tomorrow’s top stocks in emerging markets'Opinion John Citron, investment manager of the JPMorgan Emerging Markets Investment Trust, tells us where he’d put his money
-
Two ways to tap into monopoly profits from airportsMost investors can’t get their hands on airports. Here are two ways you can
-
Three British mid-caps that could make 'attractive' investmentsOpinion Charles Luke, manager of the Murray Income Trust, highlights three UK-listed mid-cap companies, as he tells us where he'd put his money
-
Fat profits: should you invest in weight-loss drugs?The latest weight-loss treatments could transform public health and the world economy. Should you invest?
-
How investors could profit from Ramsden Holdings' four-part growth strategyRamsdens Holdings offers a diversified set of financial and retail services and a juicy yield, says Dr Michael Tubbs
-
How to invest in the booming insurance marketThe insurance sector is experiencing rapid growth after years of stagnation. Smart investors should buy in now, says Rupert Hargreaves
-
Out of America's shadow: Why Trump's tariff chaos may be good for non-US stocksOpinion Upending global investment and trade could benefit other countries at the expense of the US market, says Cris Sholto Heaton
-
LendInvest: a promising fintech firm going cheapOpinion LendInvest has made some mistakes in the past, but it’s now primed for growth, says Rupert Hargreaves
